Exiguamine A, an indoleamine-2,3-dioxygenase (IDO) inhibitor isolated from the marine sponge Neopetrosia exigua

被引:101
作者
Brastianos, Harry C.
Vottero, Eduardo
Patrick, Brian O.
Van Soest, Rob
Matainaho, Teatulohi
Mauk, A. Grant [1 ]
Andersen, Raymond J.
机构
[1] Univ British Columbia, Dept Biochem & Mol Biol, Vancouver, BC V6T 1Z1, Canada
[2] Univ British Columbia, Dept Earth & Ocean Sci & Chem, Vancouver, BC V6T 1Z1, Canada
[3] Univ British Columbia, Dept Chem, Vancouver, BC V6T 1Z1, Canada
[4] Univ Amsterdam, Inst Systemat & Ecol, NL-1090 GT Amsterdam, Netherlands
[5] Univ Papua New Guinea, Discipline Pharmacol, NCD, Papua N Guinea
关键词
INDOLEAMINE 2,3-DIOXYGENASE; TRYPTOPHAN CATABOLISM; CHEMOTHERAPY; CANCER; TARGET;
D O I
10.1021/ja067211+
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
Exiguamine A (1), a hexacyclic alkaloid with an unprecedented skeleton, has been isolated from the marine sponge Neopetrosia exigua collected in Papua New Guinea. The structure of exiguamine A (1) was elucidated by a combination of spectroscopic analysis and single-crystal X-ray diffraction analysis. Exiguamine A (1) has a Ki of 210 nM for inhibition of indoleamine-2,3-dioxygenase (IDO) in vitro, making it one of the most potent IDO inhibitors known to date. A putative biogenesis for the new exiguamine skeleton starts from DOPA, tryptophan, and N,N-dimethylhydantoin. Copyright © 2006 American Chemical Society.
引用
收藏
页码:16046 / 16047
页数:2
相关论文
共 9 条
[1]   Marrying immunotherapy with chemotherapy: why say IDO? [J].
Muller, AJ ;
Prendergast, GC .
CANCER RESEARCH, 2005, 65 (18) :8065-8068
[2]   Indoleamine 2,3-dioxygenase in cancer: targeting pathological immune tolerance with small-molecule inhibitors [J].
Muller, AJ ;
Malachowski, WP ;
Prendergast, GC .
EXPERT OPINION ON THERAPEUTIC TARGETS, 2005, 9 (04) :831-849
[3]   Inhibition of indoleamine 2,3-dioxygenase, an immunoregulatory target of the cancer suppression gene Bin1, potentiates cancer chemotherapy [J].
Muller, AJ ;
DuHadaway, JB ;
Donover, PS ;
Sutanto-Ward, E ;
Prendergast, GC .
NATURE MEDICINE, 2005, 11 (03) :312-319
[4]   Prevention of allogeneic fetal rejection by tryptophan catabolism [J].
Munn, DH ;
Zhou, M ;
Attwood, JT ;
Bondarev, I ;
Conway, SJ ;
Marshall, B ;
Brown, C ;
Mellor, AL .
SCIENCE, 1998, 281 (5380) :1191-1193
[5]   Inhibition of T cell proliferation by macrophage tryptophan catabolism [J].
Munn, DH ;
Shafizadeh, E ;
Attwood, JT ;
Bondarev, I ;
Pashine, A ;
Mellor, AL .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (09) :1363-1372
[6]   Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific marine hydroid Garveia annulata [J].
Pereira, Alban ;
Vottero, Eduardo ;
Roberge, Michel ;
Mauk, A. Grant ;
Andersen, Raymond J. .
JOURNAL OF NATURAL PRODUCTS, 2006, 69 (10) :1496-1499
[7]  
SHIMIZU T, 1978, J BIOL CHEM, V253, P4700
[8]   Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase [J].
Uyttenhove, C ;
Pilotte, L ;
Théate, I ;
Stroobant, V ;
Colau, D ;
Parmentier, N ;
Boon, T ;
Van den Eynde, BJ .
NATURE MEDICINE, 2003, 9 (10) :1269-1274
[9]  
Vottero Eduardo, 2006, Biotechnology Journal, V1, P282, DOI 10.1002/biot.200600001